![John Kirby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Kirby
Financieel Directeur/CFO bij
VERRICA PHARMACEUTICALS INC.
Vermogen: 109 221 $ op 31-05-2026
Profiel
John J.
Kirby is currently a Trustee at Delaware Museum of Natural History, Inc. since 2018 and Chief Financial Officer at Verrica Pharmaceuticals, Inc. starting in 2024.
Former positions include Regional Audit Director at AstraZeneca Pharmaceuticals LP from 2010 to 2012, Chief Accounting Officer & Vice President at Shire ViroPharma, Inc. from 2012 to 2014, Assistant Controller at Endo Pharmaceuticals, Inc. from 2014 to 2015, Chief Financial Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2019 to 2022, and Chief Financial Officer at Aceragen, Inc. from 2022 to 2023.
Education includes undergraduate studies at Villanova University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-04-2026 | 18.962 ( 0,11% ) | 109 221 $ | 31-05-2026 |
Actieve functies van John Kirby
| Bedrijven | Functie | Begin |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Financieel Directeur/CFO | 05-11-2024 |
Delaware Museum of Natural History, Inc.
 Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Directeur/Bestuurslid | 01-01-2018 |
Eerdere bekende functies van John Kirby
| Bedrijven | Functie | Einde |
|---|---|---|
| ACERAGEN, INC. | Financieel Directeur/CFO | 28-04-2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Financieel Directeur/CFO | 01-09-2022 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Comptroller/Controller/Auditor | 01-10-2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Comptroller/Controller/Auditor | 01-07-2014 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Comptroller/Controller/Auditor | 01-08-2012 |
Opleiding van John Kirby
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
36
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Delaware Museum of Natural History, Inc.
Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Consumer Services |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
